GlobeNewswire 2013-09-24 BB Biotech AG : Publication pursuant to §26 sect.1 WpHG (the German Securities Trading Act) with the...
GlobeNewswire 2013-07-26 Bellevue Group remains profitable despite low turnovers
GlobeNewswire 2013-07-18 Biotech sector continues to perform well / valuations still at attractive levels despite strong sect...
GlobeNewswire 2013-06-28 BB Biotech AG : Publication pursuant to §26a WpHG (the German Securities Trading Act) with the aim o...
GlobeNewswire 2013-06-19 BB Biotech AG : Publication pursuant to §26 sect.1 WpHG (the German Securities Trading Act) with the...
GlobeNewswire 2013-04-18 Biotech sector maintains upward trend in first quarter / BB Biotech outperforms its benchmark again
GlobeNewswire 2013-03-26 Director's Dealings announcement according to §15a WpHG (the German Securities Trading Act)
GlobeNewswire 2013-03-18 Shareholders at BB Biotech's Annual General Meeting approve cash distribution of CHF 4.50 per share ...
GlobeNewswire 2013-03-18 L'Assemblea generale di BB Biotech autorizza la distribuzione in contanti di CHF 4.50 per azione / n...
GlobeNewswire 2013-03-14 BB Biotech AG completed its current share buyback program
GlobeNewswire 2013-03-14 Director's Dealings announcement according to §15a WpHG (the German Securities Trading Act)
GlobeNewswire 2013-02-25 Director's Dealings announcement according to §15a WpHG (the German Securities Trading Act)
GlobeNewswire 2013-02-25 Bellevue Group returns to profitability - impressive investment performance
GlobeNewswire 2013-02-21 Publication of the annual report 2012 of BB Biotech AG
GlobeNewswire 2013-01-24 Biotech sector still attractively valued despite its rally
GlobeNewswire 2013-01-16 BB Biotech AG earns after-tax profits of CHF 368 million in fiscal 2012
GlobeNewswire 2013-01-16 Ad hoc: BB Biotech AG earns after-tax profits of CHF 368 million in fiscal 2012
GlobeNewswire 2012-11-20 Vontobel Group withdraws its proposal to restructure BB Biotech AG into an unlisted investment fund
GlobeNewswire 2012-10-18 BB Biotech reports strong third quarter results
GlobeNewswire 2012-09-07 BB Biotech returns to TecDAX
GlobeNewswire 2012-07-19 BB BIOTECH AG: Sustainable increase of value for the company and its shareholders
GlobeNewswire 2012-07-19 BB Biotech announces structured distribution policy and specifies reasons for rejection of the propo...
GlobeNewswire 2012-07-13 BB Biotech rejects proposal by Vontobel Group
GlobeNewswire 2012-07-13 BB Biotech AG with net profit after tax of CHF 354 mn for the first half of 2012
GlobeNewswire 2012-07-13 Ad hoc: BB Biotech AG with net profit after tax of CHF 354 mn for the first half of 2012